Lipoprotein-associated phospholipase A2 and prognosis after myocardial infarction in the community.

  title={Lipoprotein-associated phospholipase A2 and prognosis after myocardial infarction in the community.},
  author={Yariv Gerber and Joseph P. McConnell and Allan S. Jaffe and Susan A. Weston and Jill M. Killian and Veronique Lee Roger},
  journal={Arteriosclerosis, thrombosis, and vascular biology},
  volume={26 11},
OBJECTIVE We evaluated the role of lipoprotein-associated phospholipase A2 (Lp-PLA2), an inflammatory biomarker, in defining risk after myocardial infarction (MI). METHODS AND RESULTS Olmsted County, Minn, residents who experienced an MI meeting standardized criteria between 2003 and 2005 (n = 271) were prospectively identified and followed. Lp-PLA2 levels were measured at baseline and evaluated along with traditional risk indicators. Lp-PLA2 was modestly associated with total and low-density… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 41 extracted citations

Lipoprotein-associated phospholipase A2 in coronary heart disease: Review and meta-analysis.

Clinica chimica acta; international journal of clinical chemistry • 2017
View 3 Excerpts

Phospholipases in Health and Disease

Paramjit S. Tappia Naranjan S. Dhalla
Advances in Biochemistry in Health and Disease • 2014


Publications referenced by this paper.
Showing 1-10 of 45 references

Similar Papers

Loading similar papers…